Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.

@article{Kessler2004PropensityFH,
  title={Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.},
  author={Craig Kessler},
  journal={Seminars in hematology},
  year={2004},
  volume={41 2 Suppl 3},
  pages={10-4}
}
Polycythemia vera (PV) and essential thrombocythemia (ET) are two myeloproliferative disorders (MPDs) with frequent thrombotic and hemorrhagic complications. Thrombosis is often the cause of mortality in PV and ET; hemorrhage occurs more commonly in idiopathic myelofibrosis patients, but is rarely fatal. Thromboses may occur in arteries or veins. Splanchnic, portal, hepatic, and splenic vein thromboses are not uncommon and thrombosis is also thought to cause placental vascular insufficiency and… CONTINUE READING